Status
Conditions
Treatments
About
In this study, the researchers want to learn more about the safety and effectiveness of Molidustat in Japanese men and women who have renal anemia, a condition in which the kidneys do not make enough of a hormone that helps the body make new red blood cells.
In previous clinical trials with a small number of participants, several important adverse events were observed. The researchers in this study want to know how many patients also have these adverse events under the real world, and if the number of the red blood cells will be increased after the treatment of Molidustat.
The researchers will collect the participants' health information from their medical records and their regular check-ups for up to 2 years. The data from this study will be submitted to the health authority in Japan in accordance with the local regulation.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
1,081 participants in 1 patient group
Loading...
Central trial contact
Bayer Clinical Trials Contact
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal